[go: up one dir, main page]

BR9304185A - Method for using a fibrin sealant, method for preparing a composition comprising fibrin monomer from fibrinogen, aqueous composition, composition, kit and solid support - Google Patents

Method for using a fibrin sealant, method for preparing a composition comprising fibrin monomer from fibrinogen, aqueous composition, composition, kit and solid support

Info

Publication number
BR9304185A
BR9304185A BR9304185A BR9304185A BR9304185A BR 9304185 A BR9304185 A BR 9304185A BR 9304185 A BR9304185 A BR 9304185A BR 9304185 A BR9304185 A BR 9304185A BR 9304185 A BR9304185 A BR 9304185A
Authority
BR
Brazil
Prior art keywords
composition
fibrin
fibrinogen
kit
preparing
Prior art date
Application number
BR9304185A
Other languages
Portuguese (pt)
Inventor
Peter Andrew David Edwardson
John Esam Fairbrother
Ronald Stephen Gardner
Derek Andrew Hollingsbee
Stuart Anth Cederholm-Williams
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of BR9304185A publication Critical patent/BR9304185A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/10—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a carbohydrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L17/00—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
    • A61L17/005—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters containing a biologically active substance, e.g. a medicament or a biocide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/225—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/06—Enzymes or microbial cells immobilised on or in an organic carrier attached to the carrier via a bridging agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/254—Enzymes, proenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Surgery (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The subject invention relates to fibrin sealants. More specifically, the subject invention relates to the use of a fibrin sealant wherein a composition comprising fibrin monomer or a composition comprising noncrosslinked fibrin is utilized as a component of the fibrin sealant. <IMAGE>
BR9304185A 1992-10-08 1993-10-08 Method for using a fibrin sealant, method for preparing a composition comprising fibrin monomer from fibrinogen, aqueous composition, composition, kit and solid support BR9304185A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95821292A 1992-10-08 1992-10-08

Publications (1)

Publication Number Publication Date
BR9304185A true BR9304185A (en) 1994-05-03

Family

ID=25500729

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9304185A BR9304185A (en) 1992-10-08 1993-10-08 Method for using a fibrin sealant, method for preparing a composition comprising fibrin monomer from fibrinogen, aqueous composition, composition, kit and solid support

Country Status (24)

Country Link
US (12) US5750657A (en)
EP (2) EP0592242B1 (en)
JP (1) JP3771284B2 (en)
KR (1) KR940008697A (en)
CN (1) CN1091315A (en)
AT (1) ATE244581T1 (en)
AU (1) AU676201B2 (en)
BR (1) BR9304185A (en)
CA (3) CA2566574A1 (en)
CZ (1) CZ211793A3 (en)
DE (1) DE69333080T2 (en)
DK (1) DK0592242T3 (en)
ES (2) ES2065294B1 (en)
FI (1) FI110616B (en)
HU (1) HU218898B (en)
IL (1) IL107211A (en)
MX (1) MX9306272A (en)
NO (1) NO314412B1 (en)
NZ (3) NZ248897A (en)
PL (3) PL175443B1 (en)
PT (1) PT592242E (en)
RU (1) RU2143924C1 (en)
SG (1) SG49640A1 (en)
SK (1) SK109393A3 (en)

Families Citing this family (258)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117425A (en) 1990-11-27 2000-09-12 The American National Red Cross Supplemented and unsupplemented tissue sealants, method of their production and use
US7208179B1 (en) * 1990-11-27 2007-04-24 The American National Red Cross Methods for treating disease and forming a supplemented fibrin matrix
US6054122A (en) 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6197325B1 (en) 1990-11-27 2001-03-06 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
CN1091315A (en) * 1992-10-08 1994-08-31 E·R·斯奎布父子公司 Fibrin sealant compositions and methods of use thereof
US6241747B1 (en) 1993-05-03 2001-06-05 Quill Medical, Inc. Barbed Bodily tissue connector
US8795332B2 (en) 2002-09-30 2014-08-05 Ethicon, Inc. Barbed sutures
ZA948564B (en) * 1993-11-19 1995-07-26 Bristol Myers Squibb Co Liquid separation apparatus and method
AU709134B2 (en) * 1994-05-02 1999-08-19 E.R. Squibb & Sons, Inc. Recombinant fibrin chains, fibrin and fibrin-homologs
EP0794823A4 (en) * 1994-12-02 1998-12-30 Bristol Myers Squibb Co REAGENT CONVEYOR FOR CENTRIFUGES
US6946079B1 (en) * 1994-12-02 2005-09-20 Bristol-Myers Squibb Company Centrifugal filtration method for separating fibrin monomer from blood
US5733446A (en) * 1994-12-02 1998-03-31 Bristol-Myers Squibb Company Centrifuge with annular filter
BR9509859A (en) * 1994-12-02 1997-09-30 Squibb & Sons Inc Method and device for separating fibrin i from blood plasma
US5605541A (en) * 1994-12-07 1997-02-25 E. R. Squibb And Sons, Inc. Fibrin sealant applicatoor
US5585007A (en) * 1994-12-07 1996-12-17 Plasmaseal Corporation Plasma concentrate and tissue sealant methods and apparatuses for making concentrated plasma and/or tissue sealant
US6074663A (en) * 1995-01-16 2000-06-13 Baxter International Inc. Method of using cross-linked fibrin material
US5733545A (en) * 1995-03-03 1998-03-31 Quantic Biomedical Partners Platelet glue wound sealant
US6551794B1 (en) * 1995-11-09 2003-04-22 E. R. Squibb & Sons, Inc. Stable biotinylated biomolecule composition
US5691152A (en) * 1995-11-09 1997-11-25 E. R. Squibb & Sons, Inc. Stable avidin composition
CA2239996C (en) 1995-12-07 2005-10-04 Bristol-Myers Squibb Company A method of applying a mixture of two liquid components
DE19781869T1 (en) * 1996-04-30 2000-03-16 Medtronic Inc Process for the production of an autologous fibrin hemostatic agent
WO2000062828A1 (en) 1996-04-30 2000-10-26 Medtronic, Inc. Autologous fibrin sealant and method for making the same
WO1998002098A1 (en) 1996-07-12 1998-01-22 Baxter International Inc. A fibrin delivery device and method for forming fibrin on a surface
DE19634313A1 (en) * 1996-08-24 1998-02-26 Behringwerke Ag Method for stabilizing platelets
US5844087A (en) * 1996-11-05 1998-12-01 Bayer Corporation Method and device for delivering fibrin glue
WO1998020931A1 (en) 1996-11-15 1998-05-22 Bristol-Myers Squibb Company Devices and methods for applying a mixture of two or more liquid components to form a biomaterial
US6613020B1 (en) 1996-12-06 2003-09-02 Bristol-Myers Squibb Company Method of applying a mixture of two liquid components as well as a device for carrying out the method
FR2757770B1 (en) * 1996-12-30 1999-02-26 Inoteb PROCESS FOR THE PREPARATION OF A BIOLOGICAL GLUE CAPABLE OF COAGULATING BY SIMPLE ADDITION OF CALCIUM IONS
US5849178A (en) * 1997-01-08 1998-12-15 Bristol-Myers Squibb Company Apparatus for separating a blood component from blood plasma
PT951642E (en) 1997-01-08 2007-02-28 Bristol Myers Squibb Co Apparatus and methods for preparing blood or plasma component solutions of known concentration
US6132598A (en) * 1997-01-08 2000-10-17 Bristol-Myers Squibb Company Centrifuge apparatus with temperature control means
US6228051B1 (en) * 1997-03-27 2001-05-08 Bristol-Myers Squibb Company Laparoscopic sealant applicator
US5971956A (en) * 1997-04-15 1999-10-26 Biosurgical Corporation Medical suctioning apparatus and methods of use
US6331172B1 (en) 1997-04-14 2001-12-18 Baxter International Inc. Applicator for dispensing measured quantities with use of controlled suction
WO1998046300A1 (en) 1997-04-14 1998-10-22 Biosurgical Corporation Fluid applicator for dispensing measured quantities with use of controlled suction
US5931855A (en) 1997-05-21 1999-08-03 Frank Hoffman Surgical methods using one-way suture
GB9711927D0 (en) * 1997-06-09 1997-08-06 Bristol Myers Squibb Co Compositions useful as fibrin sealants
US6979307B2 (en) * 1997-06-24 2005-12-27 Cascade Medical Enterprises Llc Systems and methods for preparing autologous fibrin glue
IT1292410B1 (en) * 1997-06-24 1999-02-08 Roberto Beretta READY-TO-USE CONTAINER TO OBTAIN AUTOLOGOUS FIBRIN GLUE
US7745106B2 (en) 1997-06-24 2010-06-29 Cascade Medical Enterprises, Llc Methods and devices for separating liquid components
ZA987019B (en) * 1997-08-06 1999-06-04 Focal Inc Hemostatic tissue sealants
AT407484B (en) * 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag MEDICINES FOR PROMOTING Wound Healing
US6492494B1 (en) 1997-12-09 2002-12-10 Bristol-Myers Squibb Company Method of making a fibrin sealant comprising alpha-2-antiplasmin
WO1999029838A1 (en) * 1997-12-09 1999-06-17 Bristol-Myers Squibb Company Fibrinogen-converting enzyme hybrids
US6159232A (en) 1997-12-16 2000-12-12 Closys Corporation Clotting cascade initiating apparatus and methods of use and methods of closing wounds
US6478808B2 (en) * 1997-12-17 2002-11-12 Closys Corporation Clotting cascade initiating apparatus and methods of use and methods of closing wounds
US6762336B1 (en) 1998-01-19 2004-07-13 The American National Red Cross Hemostatic sandwich bandage
NZ507786A (en) * 1998-05-06 2002-10-25 Bristol Myers Squibb Co Directional endoscopic delivery of material
US20020022588A1 (en) * 1998-06-23 2002-02-21 James Wilkie Methods and compositions for sealing tissue leaks
US6083383A (en) * 1998-06-25 2000-07-04 Huang; Xun Yang Apparatus for production of fibrin ogen or fibrin glue
US6274090B1 (en) 1998-08-05 2001-08-14 Thermogenesis Corp. Apparatus and method of preparation of stable, long term thrombin from plasma and thrombin formed thereby
JP2000070241A (en) * 1998-08-31 2000-03-07 Nissho Corp Vacuum blood collection tube for rapid coagulation
BE1012536A3 (en) 1998-11-04 2000-12-05 Baxter Int Element with a layer fibrin its preparation and use.
AU1617800A (en) * 1998-11-12 2000-05-29 Polymer Biosciences, Inc. Hemostatic polymer useful for rapid blood coagulation and hemostasis
DE19853033A1 (en) * 1998-11-18 2000-05-25 Centeon Pharma Gmbh Stabilized factor XIII and fibrinogen preparations useful as tissue adhesive components
US7276235B2 (en) * 1998-11-18 2007-10-02 Zlb Behring Gmbh Tissue glue with improved antiadhesive properties
DE10025001A1 (en) * 2000-05-22 2001-11-29 Aventis Behring Gmbh Tissue glue with improved anti-adhesive properties
KR100858830B1 (en) * 1998-11-18 2008-09-17 체에스엘 베링 게엠베하 Stabilized Protein Formulations for Tissue Conjugates
DK1143983T3 (en) * 1998-12-02 2006-04-10 Bristol Myers Squibb Co Spray delivery of cells
DE19858463A1 (en) * 1998-12-18 2000-06-21 Centeon Pharma Gmbh Use of a fibrin glue to regenerate the liver tissue
US6310036B1 (en) 1999-01-09 2001-10-30 Last Chance Tissue Adhesives Corporation High strength, Bio-compatible tissue adhesive and methods for treating vigorously bleeding surfaces
US7015198B1 (en) * 1999-05-11 2006-03-21 Orentreich Foundation For The Advancement Of Science, Inc. Materials for soft tissue augmentation and methods of making and using same
US6921412B1 (en) 1999-05-18 2005-07-26 Cryolife, Inc. Self-supporting, shaped, three-dimensional biopolymeric materials and methods
AT500670A1 (en) * 1999-05-19 2006-02-15 Bio & Bio Licensing Sa DRUGS FOR LOCAL APPLICATION
US6462018B1 (en) * 1999-06-01 2002-10-08 Bristol-Myers Squibb Company Fibrin polymer structure
AU771557B2 (en) * 1999-06-01 2004-03-25 Vivolution A/S Prevention of post surgical adhesions using a fibrin monomer sealant
AU771328B2 (en) * 1999-06-01 2004-03-18 Vivolution A/S Fibrin sealants providing less inflammatory response and methods using same
US6472162B1 (en) 1999-06-04 2002-10-29 Thermogenesis Corp. Method for preparing thrombin for use in a biological glue
CA2375346A1 (en) * 1999-06-16 2000-12-21 Bristol-Myers Squibb Company Fibrin sealant as a transfection/transformation vehicle for gene therapy
US6610043B1 (en) * 1999-08-23 2003-08-26 Bistech, Inc. Tissue volume reduction
US7654998B1 (en) * 1999-08-23 2010-02-02 Aeris Therapeutics, Inc. Tissue volume reduction
CA2316554C (en) 1999-08-25 2007-10-23 Bristol-Myers Squibb Company Applicator and electro-mechanical applicator drive system
US6463335B1 (en) 1999-10-04 2002-10-08 Medtronic, Inc. Temporary medical electrical lead having electrode mounting pad with biodegradable adhesive
CA2389283A1 (en) * 1999-10-29 2001-05-10 Bristol-Myers Squibb Company Methods for preparing blood or plasma component solutions with improved concentrations
US6730313B2 (en) 2000-01-25 2004-05-04 Edwards Lifesciences Corporation Delivery systems for periadventitial delivery for treatment of restenosis and anastomotic intimal hyperplasia
US6187347B1 (en) 2000-02-09 2001-02-13 Ecosafe, Llc. Composition for arresting the flow of blood and method
JP3576063B2 (en) * 2000-02-22 2004-10-13 株式会社ホギメディカル Soluble wound healing hemostatic cellulose fiber containing coagulation protein and method for producing the same
EP1155706A1 (en) * 2000-05-19 2001-11-21 Xun Yang Huang Apparatus for production of fibrin glue and its medical application
WO2001097872A1 (en) * 2000-06-22 2001-12-27 Austin Sam L Bioadhesive compositions and methods of preparation and use
US6921532B1 (en) * 2000-06-22 2005-07-26 Spinal Restoration, Inc. Biological Bioadhesive composition and methods of preparation and use
US20020147462A1 (en) * 2000-09-11 2002-10-10 Closure Medical Corporation Bronchial occlusion method and apparatus
JP4199004B2 (en) * 2000-11-07 2008-12-17 クライオライフ、インコーポレイテッド Foamable foam-like biomaterial and method
US6942880B1 (en) 2001-04-09 2005-09-13 Medtronic, Inc. Autologous platelet gel having beneficial geometric shapes and methods of making the same
US7795218B2 (en) 2001-04-12 2010-09-14 Bioaxone Therapeutique Inc. ADP-ribosyl transferase fusion variant proteins
US20030012818A1 (en) * 2001-04-25 2003-01-16 Eidgenossische Technische Hochschule Zurich And Universitat Zurich Drug delivery matrices to enhance wound healing
US7056331B2 (en) 2001-06-29 2006-06-06 Quill Medical, Inc. Suture method
US6994722B2 (en) 2001-07-03 2006-02-07 Scimed Life Systems, Inc. Implant having improved fixation to a body lumen and method for implanting the same
US6848152B2 (en) 2001-08-31 2005-02-01 Quill Medical, Inc. Method of forming barbs on a suture and apparatus for performing same
US6692515B2 (en) * 2001-11-07 2004-02-17 Frank H. Boehm, Jr. Surgical kit for repairing leaks in fluid carrying vessels and organs and method thereof
CA2471994A1 (en) * 2001-12-31 2003-07-17 Ares Laboratories, Llc Hemostatic compositions and methods for controlling bleeding
DE10204405A1 (en) * 2002-02-04 2003-08-21 Surface Care Gmbh Plasma gel, for use as cell culture medium, especially in production of cell transplants, tissue homogenates or wound healing compositions, comprising blood plasma, medium, calcium chloride and glycerol
AU2003225543A1 (en) * 2002-02-04 2003-09-02 Damage Control Surgical Technologies, Inc. Method and apparatus for improved hemostasis and damage control operations
US7374678B2 (en) 2002-05-24 2008-05-20 Biomet Biologics, Inc. Apparatus and method for separating and concentrating fluids containing multiple components
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US20030205538A1 (en) 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
US7992725B2 (en) 2002-05-03 2011-08-09 Biomet Biologics, Llc Buoy suspension fractionation system
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
AU2003249642A1 (en) 2002-05-24 2003-12-12 Biomet Manufacturing Corp. Apparatus and method for separating and concentrating fluids containing multiple components
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
RU2219922C1 (en) * 2002-06-28 2003-12-27 Общество с ограниченной ответственностью "Технобиофарм" Hemostatic agent
US6773450B2 (en) 2002-08-09 2004-08-10 Quill Medical, Inc. Suture anchor and method
CA2498212C (en) 2002-09-10 2012-07-17 American National Red Cross Multi-layered hemostatic dressing comprising thrombin and fibrinogen
US8100940B2 (en) 2002-09-30 2012-01-24 Quill Medical, Inc. Barb configurations for barbed sutures
US20040088003A1 (en) 2002-09-30 2004-05-06 Leung Jeffrey C. Barbed suture in combination with surgical needle
US7135027B2 (en) 2002-10-04 2006-11-14 Baxter International, Inc. Devices and methods for mixing and extruding medically useful compositions
JP3640655B2 (en) * 2002-10-23 2005-04-20 一知 井上 Angiogenesis inducer
US20050004599A1 (en) * 2003-06-30 2005-01-06 Mcnally-Heintzelman Karen M. Non-light activated adhesive composite, system, and methods of use thereof
US7943810B2 (en) 2003-02-04 2011-05-17 Buckman Robert F Method and apparatus for hemostasis
JP4585743B2 (en) * 2003-02-13 2010-11-24 独立行政法人物質・材料研究機構 Biodegradable absorbable adhesive medical material
JP5346148B2 (en) * 2003-03-28 2013-11-20 エー・デー・ガイストリヒ・ゾーネ・アクチェンゲゼルシャフト・フュール・ヒェーミシェ・インダストリー Antineoplastic compositions and methods of treatment
US20040224006A1 (en) * 2003-04-21 2004-11-11 Samn Raffaniello Ancrod irradiated, impregnated or coated sutures and other first aid or wound management bandaging materials for minimizing scarring and/or preventing excessive scar formation
US7624487B2 (en) 2003-05-13 2009-12-01 Quill Medical, Inc. Apparatus and method for forming barbs on a suture
WO2005023333A2 (en) * 2003-09-04 2005-03-17 Roy Raghunandan Supercutaneous method and device for promoting hemostasis in cannulated patient
JP2007504918A (en) 2003-09-12 2007-03-08 マリン ポリマー テクノロジーズ，インコーポレーテッド Conservation of vascular access in hemodialysis patients
CA2545874C (en) 2003-10-06 2012-02-21 3F Therapeutics, Inc. Minimally invasive valve replacement system
US7044966B2 (en) 2003-10-06 2006-05-16 3F Therapeutics, Inc. Minimally invasive valve replacement system
ES2396689T3 (en) 2003-12-11 2013-02-25 Isto Technologies Inc. Particle Cartilage System
RU2242987C1 (en) * 2003-12-15 2004-12-27 Киселев Сергей Александрович Hemostatic preparation
EP2664282B1 (en) 2004-05-14 2017-06-21 Ethicon, LLC Suture devices
EP1759718A4 (en) * 2004-05-21 2011-03-02 Chemo Sero Therapeut Res Inst Tissue closing preparation
US7670282B2 (en) 2004-06-14 2010-03-02 Pneumrx, Inc. Lung access device
JP2008503254A (en) 2004-06-16 2008-02-07 ヌームアールエックス・インコーポレーテッド Intrabronchial lung volume reduction system
US7608579B2 (en) * 2004-06-16 2009-10-27 Pneumrx, Inc. Lung volume reduction using glue compositions
US20050281798A1 (en) * 2004-06-16 2005-12-22 Glen Gong Targeting sites of damaged lung tissue using composition
US20050281740A1 (en) * 2004-06-16 2005-12-22 Glen Gong Imaging damaged lung tissue
US7678767B2 (en) 2004-06-16 2010-03-16 Pneumrx, Inc. Glue compositions for lung volume reduction
US20050281739A1 (en) * 2004-06-16 2005-12-22 Glen Gong Imaging damaged lung tissue using compositions
US7553810B2 (en) * 2004-06-16 2009-06-30 Pneumrx, Inc. Lung volume reduction using glue composition
US20050281799A1 (en) 2004-06-16 2005-12-22 Glen Gong Targeting damaged lung tissue using compositions
RU2358754C2 (en) * 2004-06-24 2009-06-20 Тобиси Фармасьютикал Ко., Лтд. Preparation inhibiting malignant tumour development and containing dis-a-fibrin
CN1980690B (en) * 2004-06-24 2011-04-13 东菱药品工业株式会社 Inhibitor of local invasion of malignant tumors containing batroxobin
WO2006014567A2 (en) 2004-07-08 2006-02-09 Pneumrx, Inc. Pleural effusion treatment device, method and material
US7766891B2 (en) 2004-07-08 2010-08-03 Pneumrx, Inc. Lung device with sealing features
US8124075B2 (en) * 2004-07-16 2012-02-28 Spinal Restoration, Inc. Enhanced biological autologous tissue adhesive composition and methods of preparation and use
US8419722B2 (en) * 2004-10-29 2013-04-16 Spinal Restoration, Inc. Apparatus and method for injection of fibrin sealant in spinal applications
US7597687B2 (en) * 2004-10-29 2009-10-06 Spinal Restoration, Inc. Injection of fibrin sealant including an anesthetic in spinal applications
US8403923B2 (en) * 2004-10-29 2013-03-26 Spinal Restoration, Inc. Injection of fibrin sealant in the absence of corticosteroids in spinal applications
US8206448B2 (en) * 2004-10-29 2012-06-26 Spinal Restoration, Inc. Injection of fibrin sealant using reconstituted components in spinal applications
ES2527056T3 (en) 2004-10-18 2015-01-20 Covidien Lp Adhesive suture structure
AU2005299672A1 (en) * 2004-10-22 2006-05-04 Benitec, Inc. Therapeutic RNAi agents for treating psoriasis
US20110213464A1 (en) * 2004-10-29 2011-09-01 Whitlock Steven I Injection of fibrin sealant in the absence of corticosteroids in spinal applications
CA2587857C (en) 2004-11-23 2017-10-10 Pneumrx, Inc. Steerable device for accessing a target site and methods
DE502006002488D1 (en) * 2005-01-14 2009-02-12 Eska Implants Gmbh & Co METHOD FOR PRODUCING AN ESTEOINDUCTIVE ANTISEPTIC IMPLANT COATING
US7866485B2 (en) 2005-02-07 2011-01-11 Hanuman, Llc Apparatus and method for preparing platelet rich plasma and concentrates thereof
EP2666493B1 (en) 2005-02-07 2020-09-23 Hanuman LLC Platelet rich plasma concentrate apparatus
US7708152B2 (en) 2005-02-07 2010-05-04 Hanuman Llc Method and apparatus for preparing platelet rich plasma and concentrates thereof
US7766900B2 (en) 2005-02-21 2010-08-03 Biomet Manufacturing Corp. Method and apparatus for application of a fluid
JP5292533B2 (en) 2005-08-26 2013-09-18 ジンマー・インコーポレイテッド Implant and joint disease treatment, replacement and treatment methods
US20070110788A1 (en) * 2005-11-14 2007-05-17 Hissong James B Injectable formulation capable of forming a drug-releasing device
RU2308287C2 (en) * 2005-12-26 2007-10-20 Владимир Александрович Макаров Hemostatic preparation
US9402633B2 (en) 2006-03-13 2016-08-02 Pneumrx, Inc. Torque alleviating intra-airway lung volume reduction compressive implant structures
US8888800B2 (en) 2006-03-13 2014-11-18 Pneumrx, Inc. Lung volume reduction devices, methods, and systems
US8157837B2 (en) 2006-03-13 2012-04-17 Pneumrx, Inc. Minimally invasive lung volume reduction device and method
US20070248653A1 (en) * 2006-04-20 2007-10-25 Cochrum Kent C Hemostatic compositions and methods for controlling bleeding
WO2007127841A2 (en) 2006-04-26 2007-11-08 Arteriocyte Medical Systems, Inc. Compositions and methods of preparation thereof
WO2007127390A2 (en) * 2006-04-28 2007-11-08 Biolife, L.L.C. Materials and methods for wound treatment
US7959943B2 (en) * 2006-05-10 2011-06-14 Medtronics Xomed, Inc. Solvating system and sealant for medical use in the middle or inner ear
US7976873B2 (en) 2006-05-10 2011-07-12 Medtronic Xomed, Inc. Extracellular polysaccharide solvating system for treatment of bacterial ear conditions
US20070264296A1 (en) * 2006-05-10 2007-11-15 Myntti Matthew F Biofilm extracellular polysachharide solvating system
US7993675B2 (en) 2006-05-10 2011-08-09 Medtronic Xomed, Inc. Solvating system and sealant for medical use in the sinuses and nasal passages
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
EP2059205B1 (en) * 2006-08-04 2012-04-04 Stb Lifesaving Technologies, Inc. Processes for the production of solid dressing for treating wounded tissue
US20100040667A1 (en) * 2006-09-07 2010-02-18 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Method of treating bone cancer
US20100297218A1 (en) * 2006-09-20 2010-11-25 Pneumrx, Inc. Tissue adhesive compositions and methods thereof
US7968682B2 (en) * 2006-12-12 2011-06-28 Oregon Health & Science University Degradation-resistant fibrinogen sealants
US8163549B2 (en) 2006-12-20 2012-04-24 Zimmer Orthobiologics, Inc. Method of obtaining viable small tissue particles and use for tissue repair
US20080154233A1 (en) * 2006-12-20 2008-06-26 Zimmer Orthobiologics, Inc. Apparatus for delivering a biocompatible material to a surgical site and method of using same
US8329870B2 (en) * 2007-01-04 2012-12-11 Hepacore Ltd. Water soluble reactive derivatives of carboxy polysaccharides and fibrinogen conjugates thereof
US8088095B2 (en) * 2007-02-08 2012-01-03 Medtronic Xomed, Inc. Polymeric sealant for medical use
GB2447012B (en) * 2007-02-21 2011-03-16 Pharmacure Health Care Ab Composition for combating epistaxis
CA2684040C (en) 2007-04-12 2016-12-06 Isto Technologies, Inc. Method of forming an implant using a mold that mimics the shape of the tissue defect site and implant formed therefrom
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
JP5479319B2 (en) 2007-04-12 2014-04-23 バイオメット・バイオロジックス・リミテッド・ライアビリティ・カンパニー Buoy suspension fractionation system
US20080255612A1 (en) 2007-04-13 2008-10-16 Angiotech Pharmaceuticals, Inc. Self-retaining systems for surgical procedures
US20090075891A1 (en) * 2007-08-06 2009-03-19 Macphee Martin Methods and dressings for sealing internal injuries
ES2398779T3 (en) 2007-09-27 2013-03-21 Ethicon Llc Self-retaining sutures that include tissue retention elements with enhanced strength
EP2222233B1 (en) 2007-12-19 2020-03-25 Ethicon, LLC Self-retaining sutures with heat-contact mediated retainers
US8916077B1 (en) 2007-12-19 2014-12-23 Ethicon, Inc. Self-retaining sutures with retainers formed from molten material
US8118834B1 (en) 2007-12-20 2012-02-21 Angiotech Pharmaceuticals, Inc. Composite self-retaining sutures and method
WO2009083544A2 (en) * 2007-12-28 2009-07-09 Kuros Biosurgery Ag Pdgf fusion proteins incorporated into fibrin foams
ES2602570T3 (en) 2008-01-30 2017-02-21 Ethicon Llc Apparatus and method for forming self-retaining sutures
US8615856B1 (en) 2008-01-30 2013-12-31 Ethicon, Inc. Apparatus and method for forming self-retaining sutures
WO2009105663A2 (en) 2008-02-21 2009-08-27 Angiotech Pharmaceuticals, Inc. Method and apparatus for elevating retainers on self-retaining sutures
US8216273B1 (en) 2008-02-25 2012-07-10 Ethicon, Inc. Self-retainers with supporting structures on a suture
US8641732B1 (en) 2008-02-26 2014-02-04 Ethicon, Inc. Self-retaining suture with variable dimension filament and method
US10106587B2 (en) 2008-02-27 2018-10-23 Biomet Biologics, Llc Methods and compositions for delivering interleukin-1 receptor antagonist
US8337711B2 (en) 2008-02-29 2012-12-25 Biomet Biologics, Llc System and process for separating a material
US8518272B2 (en) 2008-04-04 2013-08-27 Biomet Biologics, Llc Sterile blood separating system
US20090259263A1 (en) 2008-04-11 2009-10-15 Biomet Microfixation, Inc. Apparatus and methods of fixating bone
CN103083050B (en) 2008-04-15 2015-08-05 伊西康有限责任公司 There is the self-sustaining stitching thread of two-way keeper or unidirectional keeper
US8961560B2 (en) 2008-05-16 2015-02-24 Ethicon, Inc. Bidirectional self-retaining sutures with laser-marked and/or non-laser marked indicia and methods
US8012077B2 (en) 2008-05-23 2011-09-06 Biomet Biologics, Llc Blood separating device
RU2513142C2 (en) 2008-06-12 2014-04-20 Медтроник Ксомед Инк. Method of treating chronic wounds
US8632605B2 (en) 2008-09-12 2014-01-21 Pneumrx, Inc. Elongated lung volume reduction devices, methods, and systems
WO2010042427A2 (en) 2008-10-06 2010-04-15 Microbial Defense Systems, Llc Antimicrobial composition and methods of making and using same
WO2010062743A2 (en) 2008-11-03 2010-06-03 Angiotech Pharmaceuticals, Inc. Length of self-retaining suture and method and device for using the same
US8187475B2 (en) 2009-03-06 2012-05-29 Biomet Biologics, Llc Method and apparatus for producing autologous thrombin
US8110208B1 (en) 2009-03-30 2012-02-07 Biolife, L.L.C. Hemostatic compositions for arresting blood flow from an open wound or surgical site
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
US20100256671A1 (en) * 2009-04-07 2010-10-07 Biomedica Management Corporation Tissue sealant for use in noncompressible hemorrhage
WO2010129258A2 (en) 2009-04-27 2010-11-11 Mallinckrodt Inc. Tissue sealant compositions, vascular closure devices, and uses thereof
EP2432422A4 (en) 2009-05-18 2018-01-17 PneumRx, Inc. Cross-sectional modification during deployment of an elongate lung volume reduction device
US8367802B2 (en) * 2009-06-18 2013-02-05 Biomedica Management Corporation Method to produce fibrin monomer in acid media for use as tissue sealant
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
WO2011040888A1 (en) * 2009-10-01 2011-04-07 Singapore Health Services Pte Ltd A biodegradable composition or combination and uses thereof
US20110171285A1 (en) * 2009-10-28 2011-07-14 The Texas A&M University System Design of Fibrinogen and Fibrinogen Derived Products with Reduced Bacterial Binding by Using Modified Sequences of Fibrinogen Chains
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
CA2798361C (en) 2010-05-04 2018-06-12 Ethicon, Llc Laser cutting system and methods for creating self-retaining sutures
BR112012031606B1 (en) 2010-06-11 2020-11-10 Ethicon Llc suture dispenser
US10231721B2 (en) 2010-06-24 2019-03-19 St. Croix Surgical Systems, Llc Failsafe percutaneous wound barrier
EP2635198A4 (en) 2010-11-03 2015-03-18 Ethicon Llc Drug-eluting self-retaining sutures and methods relating thereto
US9675341B2 (en) 2010-11-09 2017-06-13 Ethicon Inc. Emergency self-retaining sutures and packaging
RU2746457C2 (en) 2011-03-23 2021-04-14 ЭТИКОН ЭлЭлСи Self-retaining suture with an adjustable loop
WO2012140650A2 (en) 2011-04-12 2012-10-18 Hepacore Ltd. Conjugates of carboxy polysaccharides with fibroblast growth factors and variants thereof
AU2012253476B2 (en) 2011-05-10 2015-09-24 Next Science IP Holdings Pty Ltd Antimicrobial solid and methods of making and using same
US20130172931A1 (en) 2011-06-06 2013-07-04 Jeffrey M. Gross Methods and devices for soft palate tissue elevation procedures
DE102011122227A1 (en) 2011-12-23 2013-06-27 Medizinische Hochschule Hannover Method and device for producing a bioartificial tissue construct
US20130202656A1 (en) 2012-02-03 2013-08-08 Dynasil Biomedical Corporation Systems and kits for the fabrication of tissue patches
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
EP2900297B1 (en) 2012-09-25 2018-05-23 Stem Cell Partners LLC Method and apparatus for preparing single donor thrombin serum
US10016527B2 (en) 2012-10-23 2018-07-10 Orthovita, Inc. Materials and methods for repair of cartilage defects
US20140178343A1 (en) 2012-12-21 2014-06-26 Jian Q. Yao Supports and methods for promoting integration of cartilage tissue explants
WO2014106136A1 (en) * 2012-12-31 2014-07-03 Falus George David Lyophilized fibrin sealant for high volume hemorrhage
US8906856B2 (en) * 2012-12-31 2014-12-09 Biomedica Mangement Corporation Single component fibrin hemostat
US20140222067A1 (en) * 2013-02-01 2014-08-07 Xcede Technologies, Inc. Minimally invasive surgery, including vascular closure, and associated sealants
RU2019100033A (en) 2013-02-12 2019-02-12 Репликэл Лайф Сайенсиз Инк. COMPOSITIONS AND METHODS FOR TREATMENT AND RESTORATION OF TENDONS
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
RU2522879C1 (en) * 2013-04-23 2014-07-20 ОАО "Научно-исследовательский институт текстильных материалов" (ОАО "НИИТМ") Biodegradable haemostatic therapeutic agent for control of capillary and parenchymatous bleedings
IL230151A0 (en) 2013-12-24 2014-09-30 Omrix Biopharmaceuticals Ltd One component fibrin glue comprising a polymerization inhibitor
IL230150A0 (en) 2013-12-24 2014-09-30 Omrix Biopharmaceuticals Ltd One component fibrin glue comprising zymogens
US10500233B2 (en) 2014-02-12 2019-12-10 Replicel Life Sciences Inc. Compositions and methods for treating bone, joints and cartilage
IL231230A0 (en) 2014-02-27 2014-08-31 Omrix Biopharmaceuticals Ltd Fibrinogen formulation
IL231792A0 (en) 2014-03-27 2014-08-31 Omrix Biopharmaceuticals Ltd Device and method for preparing and administering one-component fibrin sealant
BR102014011436A8 (en) * 2014-05-12 2018-01-09 Univ Estadual Paulista Julio De Mesquita Filho fibrin sealant for topical use, method of formation of fibrin and its use
US10390838B1 (en) 2014-08-20 2019-08-27 Pneumrx, Inc. Tuned strength chronic obstructive pulmonary disease treatment
US9932388B2 (en) 2014-11-13 2018-04-03 Hemarus Therapeutics Limited Chromatographic process for producing high purity fibrinogen and thrombin
US9713810B2 (en) 2015-03-30 2017-07-25 Biomet Biologics, Llc Cell washing plunger using centrifugal force
US9757721B2 (en) 2015-05-11 2017-09-12 Biomet Biologics, Llc Cell washing plunger using centrifugal force
US9540548B1 (en) 2015-08-07 2017-01-10 Xcede Technologies, Inc. Adhesive compositions and related methods
US9833538B2 (en) 2015-08-07 2017-12-05 Xcede Technologies, Inc. Adhesive compositions and related methods
CA2994959A1 (en) 2015-08-07 2017-02-16 Xcede Technologies, Inc. Adhesive compositions and related methods
US10501715B1 (en) 2015-09-11 2019-12-10 Mark H. Widick System for the formation of fibrin foam
RU2628809C1 (en) * 2016-06-30 2017-08-22 Федеральное государственное бюджетное учреждение Гематологический научный центр Министерства здравоохранения Российской Федерации (ФГБУ ГНЦ Минздрава России) Hemostatic sponge and method of its production
FR3055805B1 (en) 2016-09-09 2020-05-15 Assistance Publique - Hopitaux De Paris (Ap-Hp) BIOMATERIAL FOR THERAPEUTIC USE
CN108220233B (en) * 2016-12-21 2021-07-09 上海透景诊断科技有限公司 Cell separation instrument surface treatment method, related instrument, and method for rapidly and efficiently separating peripheral blood rare cells or circulating tumor cells
CN107589246B (en) * 2017-03-07 2019-10-01 上海原科实业发展有限公司 A kind of fibrin activator, preparation method, the kit including the activator and the detection method using the kit
RU179063U1 (en) * 2017-07-03 2018-04-25 Федеральное государственное бюджетное образовательное учреждение высшего образования "Амурская государственная медицинская академия" Министерства здравоохранения Российской Федерации Napkin with fibrin
EP3694322B1 (en) 2017-10-09 2024-07-03 Terumo BCT Biotechnologies, LLC Lyophilization container and method of using same
US11154637B2 (en) 2018-11-07 2021-10-26 Industrial Technology Research Institute Biodegradable sealant and use of a biodegradable sealant in manufacture of an agent for biological tissue adhesion or repair
CN109679946B (en) * 2019-01-04 2020-11-13 宁波艾捷康宁生物科技有限公司 Blood virus RNA protective agent and blood collection tube
JP7541993B2 (en) 2019-03-14 2024-08-29 テルモ ビーシーティー バイオテクノロジーズ，エルエルシー Freeze-drying loading tray assembly, freeze-drying system and freeze-drying method
RU2749983C1 (en) * 2020-11-09 2021-06-21 Федеральное государственное бюджетное образовательное учреждение высшего образования "Алтайский государственный медицинский университет" Министерства здравоохранения Российской Федерации Method for sealing pancreato-intestinal anastomosis using fibrin composite
CA3206002A1 (en) * 2021-01-07 2022-07-14 Baxter International Inc. Thrombin-free hemostatic materials, methods of manufacture, and uses thereof
AU2023271417A1 (en) 2022-05-17 2024-12-05 Julius-Maximilians-Universitaet Wuerzburg Novel recombinant fibrinogen variants for fibrin sealants for surgical wound care

Family Cites Families (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2533004A (en) * 1943-10-27 1950-12-05 John D Ferry Fibrin clots and methods for preparing the same
CH586233A5 (en) * 1971-01-18 1977-03-31 Pentapharm Ag
GB1417003A (en) * 1972-06-22 1975-12-10 Radiochemical Centre Ltd Stabilisation of fibrinogen
US3915640A (en) * 1974-08-06 1975-10-28 Warner Lambert Co Method and composition for detecting fibrin monomers and fibrin degradation products
SU663404A1 (en) * 1976-12-30 1979-05-25 Московский Ордена Ленина И Ордена Трудового Красного Знамени Государственный Университет Им. М.В.Ломоносова Method of obtaining fibrin monomer
US4442650A (en) * 1977-12-15 1984-04-17 Sivachenko Eugene W Girder construction
US4167823A (en) * 1978-06-21 1979-09-18 Kumming Deborah G Coagulation puzzle for teaching coagulation theory
JPS5598196A (en) * 1979-01-16 1980-07-25 Meito Sangyo Kk Fractionation of fibrinogen or its constituents and their use
SE417342B (en) * 1979-02-05 1981-03-09 Nya Asfalt Ab PROCEDURE AND DEVICE FOR THE BASIS OF COUNTRIES FOR MANUFACTURED INSTALLATIONS IN COUNTRY
AT359653B (en) * 1979-02-15 1980-11-25 Immuno Ag METHOD FOR PRODUCING A TISSUE ADHESIVE
DE3017707A1 (en) * 1980-05-08 1981-11-12 Boehringer Mannheim Gmbh, 6800 Mannheim METHOD AND REAGENT FOR DETECTING FIBRINE MONOMER
US4488198A (en) * 1981-01-15 1984-12-11 Sundstrand Corporation Protective circuit for clutchless parallel generating system
US4455290A (en) * 1981-04-02 1984-06-19 Research Corporation Inhibition of fibrin polymerization by a peptide isolated from fibrin Fragment D1
US4495278A (en) * 1981-04-27 1985-01-22 Baxter Travenol Laboratories, Inc. Process for making novel blood clotting enzyme compositions
US4480029A (en) * 1981-04-27 1984-10-30 Baxter Travenol Laboratories, Inc. Biological indicators and their use
ATE20824T1 (en) * 1981-06-25 1986-08-15 Serapharm Gmbh & Co Kg ENRICHED PLASMA DERIVES TO SUPPORT WOUND CLOSURE AND HEALING.
EP0068048B1 (en) * 1981-06-25 1985-06-19 Serapharm GmbH &amp; Co. KG Enriched plasma derivative for promoting wound sealing and wound covering
EP0068149A3 (en) * 1981-06-25 1983-07-20 Serapharm GmbH &amp; Co. KG Dry preparation containing fibrinogene, its production and use
US4442655A (en) * 1981-06-25 1984-04-17 Serapharm Michael Stroetmann Fibrinogen-containing dry preparation, manufacture and use thereof
US4438198A (en) * 1981-09-30 1984-03-20 Trimedyne, Inc. Biochemically active matrix for use in a bio-artificial organ
DE3203775A1 (en) * 1982-02-04 1983-08-11 Behringwerke Ag, 3550 Marburg FIBRINOGEN PREPARATION, METHOD FOR THEIR PRODUCTION AND THEIR USE
DE3230849A1 (en) * 1982-08-19 1984-02-23 Behringwerke Ag, 3550 Marburg PASTEURIZED HUMAN FIBRINOGEN (HF) AND METHOD FOR THE PRODUCTION THEREOF
US4927916A (en) * 1984-04-23 1990-05-22 The General Hospital Corporation Method of producing fibrin-specific monoclonal antibodies lacking fibrinogen-cross-reactivity using fibrin-specific peptides
US5357042A (en) * 1984-04-23 1994-10-18 The General Hospital Corporation Synthetic peptides capable of eliciting fibrin-specific monoclonal antibodies lacking fibrinogen-cross-reactivity
DE3430906A1 (en) * 1984-08-22 1986-02-27 Boehringer Mannheim Gmbh, 6800 Mannheim METHOD FOR DETERMINING FIBRINE MONOMER IN PLASMA
US4627879A (en) * 1984-09-07 1986-12-09 The Trustees Of Columbia University In The City Of New York Fibrin adhesive prepared as a concentrate from single donor fresh frozen plasma
US4928603A (en) * 1984-09-07 1990-05-29 The Trustees Of Columbia University In The City Of New York Method of preparing a cryoprecipitated suspension and use thereof
US5223420A (en) * 1985-03-01 1993-06-29 Institut National De La Sante Et De La Recherche Medicale Elastin-based product, a procedure for its preparation and its biological applications; in particular as biomaterials and artificial supports
SE447579B (en) * 1985-04-01 1986-11-24 Biopool Ab SOLUBILIZABLE, FIBRIN-BASED COMPOSITION AND USE OF THE COMPOSITION IN DETERMINING FIBRINOLY PARAMETERS
DE3622642A1 (en) * 1986-07-05 1988-01-14 Behringwerke Ag ONE-COMPONENT TISSUE ADHESIVE AND METHOD FOR THE PRODUCTION THEREOF
DD261844A1 (en) * 1986-07-09 1988-11-09 Adw Ddr METHOD FOR PRACTICING FIBRINMONOMERS
US4714457A (en) * 1986-09-15 1987-12-22 Robert Alterbaum Method and apparatus for use in preparation of fibrinogen from a patient's blood
DK475386D0 (en) * 1986-10-03 1986-10-03 Weis Fogh Ulla Sivertsen METHOD AND APPARATUS FOR MANUFACTURING BIOLOGICAL SUBSTANCES
US4915847A (en) * 1987-08-04 1990-04-10 Baxter International Inc. Cryoglobulin separation
GB8628398D0 (en) * 1986-11-27 1986-12-31 Central Blood Lab Authority Pharmaceutically-active conjugates
US4709037A (en) * 1987-02-17 1987-11-24 Hoechst Celanese Corporation Biotinylating agents
US5175087A (en) * 1987-07-06 1992-12-29 Biopool International, Inc. Method of performing tissue plasminogen activator assay
DE3808048A1 (en) * 1988-03-11 1989-09-21 Behringwerke Ag METHOD FOR THE AFFINITY CHROMATOGRAPHIC CLEANING OF FACTOR XIII
US5290552A (en) * 1988-05-02 1994-03-01 Matrix Pharmaceutical, Inc./Project Hear Surgical adhesive material
AT397203B (en) * 1988-05-31 1994-02-25 Immuno Ag FABRIC ADHESIVE
DE3819923A1 (en) * 1988-06-11 1989-12-21 Behringwerke Ag FIBRINE (OGEN) DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE
ATE131617T1 (en) * 1988-10-17 1995-12-15 Molecular Devices Corp HAPTEN-DERIVATIZED RECORDING MEMBRANE AND DIAGNOSTIC TESTS USING SUCH MEMBRANE
JPH02129234A (en) * 1988-11-09 1990-05-17 Kanebo Ltd Flame-retardant phenol resin prepreg
JPH02129224A (en) * 1988-11-10 1990-05-17 Terumo Corp Preparation of fibrin
DE3900493A1 (en) * 1989-01-10 1990-07-12 Thomae Gmbh Dr K METHOD FOR DETERMINING OVERALL FIBRINOLYTIC ACTIVITY IN PLASMA
US5026785A (en) * 1989-05-12 1991-06-25 The United States Of America As Represented By The Department Of Health And Human Services Avidin and streptavidin modified water-soluble polymers such as polyacrylamide, and the use thereof in the construction of soluble multivalent macromolecular conjugates
CA1335361C (en) * 1989-05-24 1995-04-25 Andrei Z. Budzynski Thrombus-targeted complexes of plasminogen activator and fibrin fragments
US5226877A (en) * 1989-06-23 1993-07-13 Epstein Gordon H Method and apparatus for preparing fibrinogen adhesive from whole blood
FR2649982B1 (en) * 1989-07-20 1991-09-27 Inst Nat Sante Rech Med ARTIFICIAL BIOLOGICAL MEMBRANE
EP0423938B1 (en) * 1989-09-29 1994-03-02 Rohm And Haas Company Ligand-containing medium for chromatographic separation, process for preparing the medium, and use of the medium for isolating synthetic or natural molecules from a fluid mixture
US5252743A (en) * 1989-11-13 1993-10-12 Affymax Technologies N.V. Spatially-addressable immobilization of anti-ligands on surfaces
US5318524A (en) * 1990-01-03 1994-06-07 Cryolife, Inc. Fibrin sealant delivery kit
US5219328A (en) * 1990-01-03 1993-06-15 Cryolife, Inc. Fibrin sealant delivery method
US5030215A (en) * 1990-01-03 1991-07-09 Cryolife, Inc. Preparation of fibrinogen/factor XIII precipitate
US5185001A (en) * 1990-01-18 1993-02-09 The Research Foundation Of State University Of New York Method of preparing autologous plasma fibrin and application apparatus therefor
US5180828A (en) * 1990-02-09 1993-01-19 Molecular Devices Corporation Chromophoric reagents for incorporation of biotin or other haptens into macromolecules
US5420250A (en) * 1990-08-06 1995-05-30 Fibrin Corporation Phase transfer process for producing native plasma protein concentrates
AU644205B2 (en) * 1990-08-23 1993-12-02 New York Blood Center, Inc., The Assays using a soluble fibrin-like monomer
AU8702491A (en) * 1990-11-08 1992-05-14 Matrix Pharmaceutical, Inc. Fibrin/collagen membrane material for biomedical use
DE69127345D1 (en) * 1990-11-13 1997-09-25 Kyowa Hakko Kogyo Kk Mitomycin derivatives
US5206023A (en) * 1991-01-31 1993-04-27 Robert F. Shaw Method and compositions for the treatment and repair of defects or lesions in cartilage
CH681693A5 (en) * 1991-02-28 1993-05-14 Pentapharm Ag
EP0534178B1 (en) * 1991-09-27 2001-04-18 Omrix Biopharmaceuticals S.A. Improved tissue glue prepared by using cryoprecipitate
US5527692A (en) * 1991-12-31 1996-06-18 Zymogenetics, Inc. Methods for producing thrombin
US5272074A (en) * 1992-04-23 1993-12-21 Mcmaster University Fibrin coated polymer surfaces
US5443959A (en) * 1992-09-09 1995-08-22 Tokuyama Corporation Method of assaying fibrinogen, dry reagent therefor, and process for the preparation thereof
CN1091315A (en) 1992-10-08 1994-08-31 E·R·斯奎布父子公司 Fibrin sealant compositions and methods of use thereof
US5292416A (en) * 1992-11-13 1994-03-08 Indiana University Foundation Pulsed-field separation of polysaccharides in capillaries
US5520885A (en) * 1993-01-19 1996-05-28 Thermogenesis Corporation Fibrinogen processing apparatus, method and container
US5330974A (en) * 1993-03-01 1994-07-19 Fibratek, Inc. Therapeutic fibrinogen compositions
EP0696201B2 (en) * 1993-03-12 2012-09-19 The American National Red Cross Supplemented tissue sealants, methods of their production and use
US5464471A (en) * 1994-11-10 1995-11-07 Whalen Biomedical Inc. Fibrin monomer based tissue adhesive
US5510102A (en) * 1995-01-23 1996-04-23 The Regents Of The University Of California Plasma and polymer containing surgical hemostatic adhesives
EP0841108A1 (en) * 1996-11-06 1998-05-13 Norsk Hydro ASA Process for connecting metal members

Also Published As

Publication number Publication date
ATE244581T1 (en) 2003-07-15
CA2510981A1 (en) 1994-04-09
PL176202B1 (en) 1999-04-30
CA2566574A1 (en) 1994-04-09
CA2510981C (en) 2007-02-13
US5770194A (en) 1998-06-23
NZ248897A (en) 1996-08-27
CN1091315A (en) 1994-08-31
EP1266666A2 (en) 2002-12-18
JP3771284B2 (en) 2006-04-26
HU218898B (en) 2000-12-28
AU676201B2 (en) 1997-03-06
EP0592242B1 (en) 2003-07-09
US6048966A (en) 2000-04-11
FI110616B (en) 2003-02-28
US5962420A (en) 1999-10-05
CA2108104C (en) 2005-09-27
NZ328064A (en) 2000-08-25
ES2065294B1 (en) 1995-11-01
IL107211A0 (en) 1994-01-25
KR940008697A (en) 1994-05-16
HU9302839D0 (en) 1994-01-28
EP1266666A3 (en) 2003-01-22
PT592242E (en) 2003-11-28
US5750657A (en) 1998-05-12
SK109393A3 (en) 1994-06-08
JPH06199685A (en) 1994-07-19
PL173858B1 (en) 1998-05-29
US5763411A (en) 1998-06-09
ES2202306T3 (en) 2004-04-01
DE69333080D1 (en) 2003-08-14
DK0592242T3 (en) 2003-10-27
HUT66587A (en) 1994-12-28
EP0592242A1 (en) 1994-04-13
NO933624D0 (en) 1993-10-08
CZ211793A3 (en) 1996-04-17
NZ280264A (en) 1997-08-22
MX9306272A (en) 1994-07-29
NO314412B1 (en) 2003-03-17
AU4887893A (en) 1994-04-21
SG49640A1 (en) 1998-06-15
FI934440A0 (en) 1993-10-08
IL107211A (en) 1997-09-30
DE69333080T2 (en) 2004-04-15
US6262236B1 (en) 2001-07-17
CA2108104A1 (en) 1994-04-09
US5962026A (en) 1999-10-05
ES2065294A1 (en) 1995-02-01
US5763410A (en) 1998-06-09
PL175443B1 (en) 1998-12-31
FI934440L (en) 1994-04-09
US5739288A (en) 1998-04-14
US6077507A (en) 2000-06-20
RU2143924C1 (en) 2000-01-10
US5804428A (en) 1998-09-08
NO933624L (en) 1994-04-11
US5773418A (en) 1998-06-30

Similar Documents

Publication Publication Date Title
BR9304185A (en) Method for using a fibrin sealant, method for preparing a composition comprising fibrin monomer from fibrinogen, aqueous composition, composition, kit and solid support
RU93058414A (en) METHODS FOR USING FIBRINE SEALANT, METHOD FOR PRODUCING COMPOSITION, COMPOSITION, KITS
DE69316717D1 (en) Double-acting inhibitors
ES2019899B3 (en) TRANS-6- [2 (3- O 4-CARBOXAMIDOPYROL SUBSTITUTED-1-IL) -ALKYL] 4-HYDROXIPIRAN-2-ONA INHIBITORS FOR CHOLESTEROL SYNTHESIS.
FI964520L (en) Azabicyclo compounds
EA199900141A1 (en) COLOR-FORMING COMPOSITION, CONTAINING REAGENT, INCLUDING PYROGALLIUM STRUCTURAL FRAGMENTS, SALT (IRON) AND ORGANIC ACID
DK0736501T3 (en) Procedure for spraying concrete or mortar
DE60000616D1 (en) Compositions containing mineral water
FI955498A0 (en) Nipecotinic acid derivatives as anticoagulants
DK0545199T3 (en) Use of fungal mycelium as a soil conditioner
HUP9700128A1 (en) Hardening mortar
EA199900888A1 (en) ANTI-RELATED MEANS
RU1833365C (en) METHOD FOR OBTAINING TP AND IDENTIFIED SOLO COMPOUNDS
PT98268A (en) PROCESS FOR THE PREPARATION OF INDANO-PYRROLIDINE-CARBAMATES
FI903950A0 (en) NY COMPOSITION.
BR9405186A (en) Process for the preparation of 2,4,5-tribromopyrrole-3-carbonitrile
ES2134513T3 (en) COMPATIBILIZERS CONTAINING PYRROLIDINONE.
FR2717174B1 (en) Use of piperidinoethyl esters of 4-amino-5-chloro-2-methoxybenzoic acid as 5-HT4 agonists.
DE59002172D1 (en) NEW 1,3-OXAZINE.
FR2712494B1 (en) Process for obtaining an expectorant composition of plant origin as well as an expectorant composition.
FI944967L (en) Methods for preparing saccharin derivatives and intermediates thereof useful as proteolytic enzyme inhibitors

Legal Events

Date Code Title Description
EE Request for examination
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
CKFC Appeal: appeal against refusal